WISCONSIN (CoinChapter.com) — On Sep. 5, US stock markets dropped, with the Dow Jones Industrial Average declining 0.23% and the S&P 500 and NASDAQ Composite falling by 0.4%.
Here are the five best stock market gainers:
Helius Medical Technologies Inc. (NASDAQ: HSDT)
Helius Medical Technologies Inc. (NASDAQ: HSDT), a leading neurotech company, has demonstrated its compliance with the NASDAQ listing requirements, sending shares up 54.06%. On August 31, 2023, Helius received an official notice from the Listing Qualifications staff of The NASDAQ Stock Market LLC.
This notification confirmed that Helius Medical complies with the minimum bid price requirement as per NASDAQ Listing Rule 5550(a)(2) and satisfies all other requisite criteria for continued listing.
GD Culture Group Ltd. (NASDAQ: GDC)
GD Culture Group Ltd. (NASDAQ: GDC), a holding company operating via Shanghai Highlight Media and AI Catalysis Corp, had no news announcements Tuesday. Eight days ago, the company announced its expansion into live streaming on TikTok.
AI Catalysis has launched an interactive live-streaming game on the platform that offers real-time and immersive gaming experiences. The game encourages viewers to participate actively, allowing them to choose one of two teams and compete against each other. Investors sent shares 21.68% higher in trading today.
AudioEye Inc. (NASDAQ: AEYE)
AudioEye Inc. (NASDAQ: AEYE), an enterprise SaaS accessibility firm, unveiled findings from a comprehensive analysis of more than 900 known legal claims within the accessibility industry on August 15, 2023. Investors continue to be optimistic, which sent shares 18.53% higher today.
AudioEye’s data revealed that customers using the company’s digital accessibility solution are 67% less likely to receive a valid lawsuit claim compared to users of other industry solutions. This suggests that AudioEye provides significant legal protection in an industry where lawsuits continue to surge, with over 1,950 cases filed in the first half of 2023 alone.
Cabaletta Bio Inc. (NASDAQ: CABA)
Cabaletta Bio Inc. (NASDAQ: CABA), a clinical-stage biotechnology company, announced its participation in four investor conferences this September. The company, known for its focus on developing and launching pioneering targeted cell therapies for autoimmune diseases, continues to engage with the investment community.
The 2023 Wells Fargo Healthcare Conference will see Cabaletta Bio’s management members available for individual meetings in Boston, MA, on Sep. 6, 2023. Furthermore, Gwendolyn Binder, Ph.D., the President of Science and Technology at Cabaletta Bio, will contribute to a panel discussion at Citi’s 18th Annual BioPharma Conference.
Addentax Group Corp. (NASDAQ: ATXG)
Addentax Group Corp. (NASDAQ: ATXG), a multifaceted service provider specializing in garment manufacturing, logistics services, property management, and subleasing, has launched strategic negotiations with Xianglilai Technology Co., Ltd. The stock went 14.53% higher on today’s positive news release.
This Chinese firm specializes in lithium battery research & development, manufacturing, and operations.
The initiative is consistent with Addentax’s recent commitment to its joint venture with Auto City (Shenzhen) Autonomous Driving Co., Ltd, established around June 6, 2023, primarily focusing on artificial intelligence (AI) cloud-based solutions.
